Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin
| Autor: | Ziye Zhou, Dawei Shi, Xiangxiang Jin, Xiaofeng Pan |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Liver Cirrhosis Male Peptic Ulcer Gastrointestinal bleeding medicine.medical_specialty Cirrhosis Serum Albumin Human 030226 pharmacology & pharmacy Gastroenterology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Risk Factors Internal medicine medicine Humans Vasoconstrictor Agents Pharmacology (medical) 030212 general & internal medicine Risk factor Aged Retrospective Studies Pharmacology Creatinine Dose-Response Relationship Drug business.industry Sodium nutritional and metabolic diseases Odds ratio Middle Aged medicine.disease chemistry Concomitant Female Gastrointestinal Hemorrhage Terlipressin business Hyponatremia medicine.drug |
| Zdroj: | Journal of Clinical Pharmacy and Therapeutics. 45:191-198 |
| ISSN: | 1365-2710 0269-4727 |
| Popis: | What is known and objective As terlipressin becomes more widely used in clinical practice, more papers had reported the correlation between hyponatremia and terlipressin treatment. This study was performed to evaluate the clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin and the effects of concomitant drugs. Methods We conducted a retrospective evaluation of patients with cirrhosis treated with terlipressin at the gastroenterology department of Hospital between 1 January 2016 and 30 June 2018. Patients treated with terlipressin for gastrointestinal bleeding due to peptic ulcer and other non-hepatic factors were excluded. Results and discussion After the patients received terlipressin, their serum sodium concentrations decreased from 138.2 ± 4.3 mmol/L to 129.3 ± 7.2 mmol/L. Statistically significant differences were observed with respect to sex, initial serum sodium concentration, lowest serum sodium concentration, hyponatremia duration and total drug dose. Among the patients with hyponatremia, statistically significant differences in albumin level, serum creatinine level, hyponatremia duration and total drug dose were found between the patients with severe hyponatremia and those with non-severe hyponatremia. Logistic regression analysis revealed that initial serum sodium concentration (odds ratio, 95% confidence interval: 18.475, 3.967-86.035; P = .000) was a risk factor for reduced serum concentration, and that albumin level (1.105, 1.012-1.207; P = .026), serum creatinine level (0.975, 0.952-0.997; P = .028) and hyponatremia duration (1.297, 1.064-1.583; P = .010) were risk factors of severe hyponatremia. What is new and conclusion The incidence of severe hyponatremia among patients with cirrhosis who are treated with terlipressin is high. Moreover, higher initial serum sodium concentrations and increased duration of terlipressin administration are associated with a higher the incidence of severe hyponatremia. The initial albumin level is a risk factor for severe hyponatremia as is serum creatinine, although the latter is negatively correlated with the occurrence of the condition. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|